The structural differences between the apoE isoforms translate into significant functional changes with implications in pathophysiological conditions including dyslipidemia, cardiovascular diseases, neurodegenerative disorders, infections and inflammatory states. This evidence concerns the gene APOE and metabolic syndrome.